| Company/Division name | TempraMed |
| Parent company | TempraMed |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2025 |
| Country(ies) from which reshored: | Israel |
| State(s) reshored to: | FL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | medical equipment |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Proximity to customers/market |
